|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Phase 2 trial of eritoran tetrasodium (E5564), a toll- like receptor 4 antagonist, in patients with severe sepsis显示文摘 | Tidswell M Tillis W Larosa SP | 2010 | Crit Care Med2010，38，1： | 1 |
| 2 | Phase 2 trial of eritoran tetrasodium (E5564), a toll-like receptor 4 antagonist, in pa- tients with severe sepsis 显示文摘 | Tidswell M Tillis W Larosa SP et ol | 2010 | Crit Care Med2010，38，1： | 1 |
| 3 | Hemodynamic consequences of heart-lung interactions显示文摘 | Steingrub JS Tidswell M Higgins TL | 2003 | J Intensive Care Med2003，18，2： | 1 |
| 4 | Hemodynamic consequences of heart-lung interactions 显示文摘 | Steingrub JS Tidswell M Higgins TL | 2003 | Intensive Care Med2003，18，2： | 1 |
| 5 | Phase 2 trial of eritoran tetrasodium ( E5504 ) , a Toll-like receptor 4 antagonist, in pati- ents with severe sepsis 显示文摘 | Tidswell M Tillis W Lalrosa SP | 2010 | Crit Care Med2010，38，1： | 1 |
| 6 | Phase 2 trial of eritoran tetrasodium(E5564),a toll-like receptor 4 antagonist,in patients with severe sepsis显示文摘 | Tidswell M Tillis W Larosa SP | | 0，，： | 1 |
| 7 | Hemodynamic consequences of heartlung interactions显示文摘 | Steingrub J S Tidswell M Higgins T L | 2003 | J Intensive Care Med2003，18，2： | 1 |
| 8 | Phase 2 trial of eritoran tetrasodium (E5564), a Toll-like receptor 4 antagonist, in pa- tients with severe sepsis显示文摘 | Tidswell M Tillis W Larosa SP | 2010 | Cfit Care Med2010，38，1： | 1 |
| 9 | Phase 2 trial of eritoran tetrasodium (E5564), a toll-like receptor 4 antagonis, in patients with severe sepsis 显示文摘 | TIDSWELL M TILLS W LAROSA SP et ol | 2010 | Crit Care Med2010，38，1： | 1 |
| 10 | Hemodynamic consequences of heart-lung interactions显示文摘 | Steingrub JS Tidswell M Higgins TL | 2004 | J Intensive Care Med2004，18，2： | 1 |
| 11 | Phase 2 trial of erioran tetrasodium ( E5564 ) , a toll-like receptor 4 antagonist, in patients with severe sepsis显示文摘 | Tidswell M Tillis W Laross SP | 2010 | Crit Care Med2010，38，1： | 1 |
| 12 | Phase 2 trial of eritoran tetrasodium (E5564), a toll-like receptor 4 antagonist, in patients with severe sepsis显示文摘 | TIDSWELL M TILLIS W LAROSA S P | 2010 | Crit Care Med2010，38，1： | 1 |
| 13 | Peripartum Cardiomyopathy显示文摘 | Tidswell M | 2004 | Crit Care Clin2004，20，： | 1 |
| 14 | Phase 2 trial of tetrasodium ( E5564 ), a toll-like receptor 4 antagonist, in patients with severe sepsis显示文摘 | Tidswell M Tillis W Larosa SP | 2010 | Crit Care Med2010，38，9： | 1 |
| 15 | Phase 2 trial of tetrasodium (E5564),a toll-like receptor 4 antagonist,in patients with severe sepsis显示文摘 | TIDSWELL M TILLIS W LAROSA SP | 2010 | Crit Care Med2010，38，1： | 1 |
| 16 | Peripartum eardiomyopathy 显示文摘 | Tidswell M | 2004 | Crit Care Clin2004，20，4： | 1 |
| 17 | Hemodynamic consequences of heart-lung interactions显示文摘 | Steingrub JS Tidswell M Higgins TL | 2003 | J Intensive Care Med2003，18，2： | 1 |
| 18 | Phase 2 trial of eritoran tetrasodium ( E5564 ), a Toll like receptor 4 antagonist in patients with severe sepsis显示文摘 | Tidswell M Tillis W Larosa S P | 2010 | Critical Care Medicine2010，38，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员